JE

Johnston Erwin

Chief Executive Officer

TRexBio

Carmel, Indiana


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
TRexBio
Industry
research
Employees
55.0
Seniority
C suite
Annual Revenue
2200000.0
Total Funding
169000000.0
Latest Funding
Series B

Technologies

Mimecast Microsoft Office 365 BugHerd Google Font API Google Tag Manager Gravity Forms WordPress.org Mobile Friendly Render Python Remote

Keywords

biotechnology t cell biology bioinformatics human immunology regulatory t cell biotechnology research immune-mediated diseases regulatory t cells treg modulation deep biology platform therapeutics development autoimmune diseases inflammatory diseases human tissue biology computational biology functional genomics rna sequencing disease processes therapeutic candidates clinical trials high-throughput screening immunobiology biological pathways tissue homeostasis novel biology disease-relevant assays pipeline of therapeutics anti-inflammatory treatments tnfr2 agonist translational insights drug discovery multidisciplinary approach immunological assays clinical development scrna sequencing immune homeostasis therapeutic innovation pathway mapping tissue-specific therapies collaboration with eli lilly collaborative research candidates for drug approval sophisticated computational tools adequate target identification therapeutics customization immunoregulatory pathways drug candidate pipeline tissue regulatory t-cell biopharmaceutical innovation chronic immune conditions tissue engineering strategies cellular biology high resolution profiling information technology & services health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans